Mitochondrial dysfunction and effect of antiglycolytic bromopyruvic acid in GL15 glioblastoma cells

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Bioenergetics and Biomembranes

• Publication date

  2011-07-21

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s10863-011-9375-2PMID 21833601
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• H(2)O(2) disposal in cardiolipin-enriched brain mitochondria is due to increased cytochrome c peroxidase activity.

  2011cited by this paper
• 3-Bromopyruvate induces necrotic cell death in sensitive melanoma cell lines.

  2010cited by this paper
• 3-bromopyruvate: a new targeted antiglycolytic agent and a promise for cancer therapy.

  2010cited by this paper
• CXCL12-induced glioblastoma cell migration requires intermediate conductance Ca2+-activated K+ channel activity.

  2010cited by this paper
• Inhibition of energy-producing pathways of HepG2 cells by 3-bromopyruvate.

  2009cited by this paper
• Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

  2009cited by this paper
• Loss of cardiolipin in palmitate‐treated GL15 glioblastoma cells favors cytochrome c release from mitochondria leading to apoptosis

  2008cited by this paper
• Cardiolipin deficiency leads to decreased cardiolipin peroxidation and increased resistance of cells to apoptosis.

  2008cited by this paper
• Role of reactive oxygen species-mediated mitochondrial dysregulation in 3-bromopyruvate induced cell death in hepatoma cells

  2008cited by this paper
• Proautophagic drugs: a novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas.

  2007cited by this paper
• Age-related Oxidative Modifications of Proteins and Lipids in Rat Brain

  2007cited by this paper
• Warburg, me and Hexokinase 2: Multiple discoveries of key molecular events underlying one of cancers’ most common phenotypes, the “Warburg Effect”, i.e., elevated glycolysis in the presence of oxygen

  2007cited by this paper
• Protein Degradation within Mitochondria: Versatile Activities of AAA Proteases and Other Peptidases

  2007cited by this paper
• Examination of the therapeutic potential of Delta-24-RGD in brain tumor stem cells: role of autophagic cell death.

  2007cited by this paper
• Alteration of mitochondrial function and cell sensitization to death

  2007cited by this paper
• Mitochondria in cancer

  2006cited by this paper
• GL15 and U251 glioblastoma-derived human cell lines are peculiarly susceptible to induction of mitotic death by very low concentrations of okadaic acid.

  2006cited by this paper
• Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus.

  2006cited by this paper
• Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.

  2005cited by this paper
• Activation of glycogen synthase kinase 3beta disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity.

  2005cited by this paper
• Proteomic characterization of harvested pseudopodia with differential gel electrophoresis and specific antibodies

  2005cited by this paper
• Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors

  2005cited by this paper
• Matrix metalloproteinase-2 contributes to cancer cell migration on collagen.

  2005cited by this paper
• Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis

  2005cited by this paper
• Recently elucidated energy catabolism pathways provide opportunities for novel treatments in hepatocellular carcinoma

  2004cited by this paper
• Advanced cancers: eradication in all cases using 3-bromopyruvate therapy to deplete ATP.

  2004cited by this paper
• Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidylserine.

  2004cited by this paper
• Catalytic unfolding and proteolysis of cytochrome C induced by synthetic binding agents.

  2004cited by this paper
• Migrating glioma cells activate the PI3-K pathway and display decreased susceptibility to apoptosis

  2003cited by this paper
• Generation of reactive oxygen species by the mitochondrial electron transport chain

  2002cited by this paper
• Stable transfection of cDNAs targeting specific steps of glycogen metabolism supports the existence of active gluconeogenesis in mouse cultured astrocytes

  2002cited by this paper
• Novel therapy for liver cancer: direct intraarterial injection of a potent inhibitor of ATP production.

  2002cited by this paper
• Exogenous Phospholipids Specifically Affect Transmembrane Potential of Brain Mitochondria and Cytochrome cRelease*

  2002cited by this paper
• Gliomagenesis: genetic alterations and mouse models

  2001cited by this paper
• Malignant glioma: genetics and biology of a grave matter.

  2001cited by this paper
• Protein degradation in mitochondria: implications for oxidative stress, aging and disease: a novel etiological classification of mitochondrial proteolytic disorders.

  2001cited by this paper
• Glucose catabolism in the rabbit VX2 tumor model for liver cancer: characterization and targeting hexokinase.

  2001cited by this paper
• Interleukin-1beta induces apoptosis in GL15 glioblastoma-derived human cell line.

  2000cited by this paper
• Interleukin-1β induces apoptosis in GL15 glioblastoma-derived human cell line

  2000cited by this paper
• Glycogen in astrocytes: possible function as lactate supply for neighboring cells.

  1993cited by this paper
• Glycolysis as primary energy source in tumor cell chemotaxis.

  1990cited by this paper
• On the origin of cancer cells.

  1956cited by this paper
• [Origin of cancer cells].

  1956cited by this paper

• L-Glyceraldehyde Inhibits Neuroblastoma Cell Growth via a Multi-Modal Mechanism on Metabolism and Signaling

  2024cites this paper
• TRIM13 inhibits cell proliferation and induces autophagy in lung adenocarcinoma by regulating KEAP1/NRF2 pathway

  2023cites this paper
• The Role of ER Stress-Related Phenomena in the Biology of Malignant Peripheral Nerve Sheath Tumors

  2021cites this paper
• Unfolding the role of autophagy in the cancer metabolism

  2021cites this paper
• The efficacy of the anticancer 3-bromopyruvate is potentiated by antimycin and menadione by unbalancing mitochondrial ROS production and disposal in U118 glioblastoma cells

  2020cites this paper
• Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model

  2020cites this paper
• The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells.

  2018cites this paper
• Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma

  2018cites this paper
• Interaction between 3-Bromopyruvate and SC-514 in prostate cancer treatment

  2018cites this paper
• Monocarboxylate transporter 1 (MCT1), a tool to stratify acute myeloid leukemia (AML) patients and a vehicle to kill cancer cells

  2017cites this paper
• The Typical Metabolic Modifiers Conferring Improvement in Cancer Resistance.

  2017cites this paper
• 3-Bromopyruvate treatment induces alterations of metabolic and stress-related pathways in glioblastoma cells.

  2017cites this paper
• The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside

  2016cites this paper
• Role of Redox Status in Development of Glioblastoma

  2016cites this paper
• Nitrones as Potent Anticancer Therapeutics

  2016cites this paper
• Changes in mitochondrial morphology induced by calcium or rotenone in primary astrocytes occur predominantly through ros‐mediated remodeling

  2015cites this paper
• PERK silence inhibits glioma cell growth under low glucose stress by blockage of p-AKT and subsequent HK2's mitochondria translocation

  2015cites this paper
• Differentiate or Die: 3-Bromopyruvate and Pluripotency in Mouse Embryonic Stem Cells

  2015cites this paper
• The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes

  2015cites this paper
• The energy blockers 3-bromopyruvate and lonidamine: effects on bioenergetics of brain mitochondria

  2014cites this paper
• Regulation of Death Induction and Chemosensitizing Action of 3-Bromopyruvate in Myeloid Leukemia Cells: Energy Depletion, Oxidative Stress, and Protein Kinase Activity Modulation

  2014influential citation
• Autophagy Inhibition Promotes 5-Fluorouraci-Induced Apoptosis by Stimulating ROS Formation in Human Non-Small Cell Lung Cancer A549 Cells

  2013cites this paper
• Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.

  2013cites this paper
• The role of metabolism and mitochondrial function in embryonic stem cells

  2013cites this paper
• Bromopyruvate mediates autophagy and cardiolipin degradation to monolyso-cardiolipin in GL15 glioblastoma cells

  2012cites this paper
• 3-bromopyruvate: Targets and outcomes

  2012cites this paper
• Targeting aerobic glycolysis: 3-bromopyruvate as a promising anticancer drug

  2012cites this paper